Schimrigk S, et al. - Researchers carried out a clinical trial to show efficacy and long-term safety of dronabinol in the treatment of patients with multiple sclerosis (MS) and central neuropathic pain (CNP). In this study, dronabinol was found to be a safe long-term treatment option.